European Medicines Agency: Benefits of AstraZeneca vaccine continue to outweigh the risks
India Today
Europe's medicines watchdog said on Tuesday the benefits of AstraZeneca's Covid-19 vaccine continue to outweigh the risks after several countries halted its use due to concerns about blood clots.
Europe's medicines watchdog said on Tuesday the benefits of AstraZeneca's Covid-19 vaccine continue to outweigh the risks after several countries halted its use due to concerns about blood clots. EMA Executive Director Emer Cooke said there was no indication that the blood clot incidents, which she called "very rare" had been caused by the vaccine, but that experts were assessing that possibility. Trust in the safety of the vaccines was paramount and the agency was carrying out a case-by-case evaluation, she said.More Related News